TrialBMC cancer2022

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.

Akira Ooki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.